US 11312756
Engineered potent cytotoxic stapled BH3 peptides
granted A61KA61K31/635A61K38/00
Quick answer
US patent 11312756 (Engineered potent cytotoxic stapled BH3 peptides) held by THE TRUSTEES OF PRINCETON UNIVERSITY expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE TRUSTEES OF PRINCETON UNIVERSITY
- Grant date
- Tue Apr 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/635, A61K38/00, A61K38/10, A61K38/12